Systemic fungal infection following effective pain relief with high-dose steroid therapy for terminal cancer pain: A case report.
10.17085/apm.2015.10.1.61
- Author:
Yi Hwa CHOI
1
;
Dong Jin CHANG
;
Sung Min JOO
;
Soo Kyung LEE
;
Mae Hwa KANG
;
Eun Young PARK
Author Information
1. Department of Anesthesiology and Pain Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea. djchang@hallym.or.kr
- Publication Type:Case Report
- Keywords:
Candida;
Pain;
Steroids
- MeSH:
Candida;
Humans;
Neoplasm Metastasis;
Steroids
- From:Anesthesia and Pain Medicine
2015;10(1):61-63
- CountryRepublic of Korea
- Language:English
-
Abstract:
High-dose steroid therapy is known as effective adjuvant therapy for refractory bone pain due to metastasis of solid cancer. However, the standard dose and duration have not been established to date. Long term maintenance with steroid therapy is not encouraged due to its potential adverse effects. Here, we report a case of a terminal cancer patient who maintained high dose steroid therapy to alleviate refractory bone pain with complication of systemic fungal infection.
